Acanthe Développement (LON:0DYL)
0.2660
-0.0090 (-3.27%)
At close: Oct 1, 2025
Acanthe Développement Revenue
Acanthe Développement had revenue of 1.78M EUR in the half year ending June 30, 2025, a decrease of -10.40%. This brings the company's revenue in the last twelve months to 3.73M, down -5.50% year-over-year. In the year 2024, Acanthe Développement had annual revenue of 3.92M, down -1.16%.
Revenue (ttm)
3.73M EUR
Revenue Growth
-5.50%
P/S Ratio
11.29
Revenue / Employee
466.50K EUR
Employees
8
Market Cap
36.13M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92M | -46.00K | -1.16% |
| Dec 31, 2023 | 3.97M | 229.00K | 6.13% |
| Dec 31, 2022 | 3.74M | -132.00K | -3.41% |
| Dec 31, 2021 | 3.87M | -965.00K | -19.96% |
| Dec 31, 2020 | 4.84M | -650.00K | -11.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |